Meet Valar MBA Alumnus, Jayden Lee, a clinical pharmacist turned biotech entrepreneur, committed to revolutionizing healthcare through genomics and artificial intelligence. His journey is one of transformation, resilience, and a relentless drive to improve health outcomes on a global scale.

Jayden began his career in clinical pharmacy, working directly with patients and developing a deep passion for improving individual and population health. However, he soon realized that to drive systemic change, he needed to shift from one-on-one patient care to innovating at scale. This led him to co-found UGenome AI, a genomics software startup poised to redefine disease prevention, management, and treatment. With the genomics industry projected to reach $158 billion by 2033, Jayden stands at the forefront of this rapidly growing field.

Transitioning from healthcare to biotech was not without challenges. Stepping into the world of entrepreneurship meant acquiring new skills in business strategy, leadership, and innovation, which led Jayden to pursue an MBA at Valar. The program provided him with the tools and frameworks to navigate complex business landscapes while launching and scaling his company.

Leadership, for Jayden, is about authenticity, patience, and empowering others. Inspired by his wife, a mother, PhD, and role model of resilience, he has learned the value of humility and effective communication in building strong teams and driving meaningful change. “Leadership isn’t about having all the answers,” he shares. “It’s about listening, learning, and fostering an environment where innovation thrives,” states Jayden.

The global biotech sector is evolving rapidly, with breakthroughs in genomics opening new doors for personalized medicine, early disease detection, and AI-driven healthcare solutions. Jayden’s work at UGenome AI contributes to this transformation, leveraging cutting-edge technology to make healthcare more precise, proactive, and accessible.

Through the Valar MBA program, Jayden has sharpened his ability to make data-driven decisions, refine his leadership approach, and scale his startup in a highly competitive industry. The program’s emphasis on real-world applications has helped him bridge the gap between healthcare and business, ensuring that his innovations can translate from research to real-world impact.

For Jayden, the future of healthcare lies at the intersection of science, technology, and leadership. As he continues to grow as an entrepreneur, he remains committed to driving innovation with purpose, shaping a healthier, more data-driven world for generations to come.